Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 30 (5), 697-698
- https://doi.org/10.1016/0959-8049(94)90548-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.Journal of Clinical Oncology, 1993
- Treatment of advanced ovarian cancer: 10 years of experienceAnnals of Oncology, 1992
- Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptorsCancer, 1991
- High-dose medroxyprogesterone acetate in advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1991
- Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: An EORTC gynecological cancer cooperative group studyGynecologic Oncology, 1985
- Noncontraceptive health benefits of oral steroidal contraceptivesAmerican Journal of Obstetrics and Gynecology, 1982